Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Buy, Sell, or Hold SoFi Stock After Apple’s Announcement?

By Chris Lau, InvestorPlace Contributor

SoFi stock investors are panic because Apple is entering the buy now, pay later market, which could devastate SoFi’s business model.

Shopify Stock Has Taken a Beating, But a Small Position Is a Good Idea

By Chris Lau, InvestorPlace Contributor

Shopify’s CEO voting power is a positive development as SHOP stock investors continue their belief in the company’s growth trajectory.

The Rebound In Nio Stock Is Just Getting Started

By Chris Lau, InvestorPlace Contributor

Nio's May delivery update revealed the start of a recovery that should benefit NIO stock holders in the months ahead.

7 Tempting Tech Stocks to Pull the Trigger on Now

By Chris Lau, InvestorPlace Contributor

When markets dip hard enough and are about to rebound, investors will flock to these big stock names first as they seek safety.

Teladoc Can’t Rely On Hype To Attract Investors

By Chris Lau, InvestorPlace Contributor

Investors should think twice before buying TDOC stock, considering the negative impact of the stay-at-home phase ending.

Load More